Media playback is unsupported on your device

'Obamacare' boost to Indian pharmaceutical industry

4 October 2013 Last updated at 02:44 BST

Whilst the introduction of President Obama's healthcare reforms has proved controversial in the US, in India it is expected to boost the pharmaceutical industry.

India produces nearly 40% of the generic drugs used in the US and has been stepping up production in anticipation of increased demand in the wake of the introduction of "Obamacare".

The BBC's Brajesh Upadhyay, in Washington DC, explains.

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.